| ACANYA® |
(clindamycin phosphate and benzoyl peroxide) Gel, 1.2% or 2.5%, for Topical Use |
| ALDARA® |
Cream 5% |
| ALREX® |
(loteprednol etabonate ophthalmic suspension) 0.2% |
| ANCOBON® |
(flucytosine) 500 mg Capsules |
| APLENZIN® |
(bupropion hydrobromide) Extended-Release Tablets, 174 mg, 348 mg and 522 mg |
| ARAZLO® |
(tazarotene) Lotion, 0.045% |
| ATOPICLAIR® |
Nonsteroidal Cream 100 g Tube |
| BENZAMYCIN GEL® |
46.6 g |
| BEPREVE® |
(bepotastine besilate ophthalmic solution) 1.5% |
| BESIVANCE® |
(besifloxacin ophthalmic suspension) 0.6% |
| BIAFINE® |
45 g Topical Emulsion |
| BRYHALI™ |
(halobetasol propionate) Lotion, 0.01% 60 g or 100 g |
| CARAC® |
(fluorouracil cream) Cream, 0.5% |
| CLINDAGEL® |
(clindamycin phosphate gel) Topical Gel, 1% |
| CUPRIMINE® |
(penicillamine) Capsules |
| CYCLOSET® |
(bromocriptine mesylate tablets), for Oral Use |
| DEMSER® |
(metyrosine) Capsules |
| DUOBRII™ |
(halobetasol propionate and tazarotene 0.01%/0.45%) 100 g for Topical Use |
| EFUDEX® |
(fluorouracil) Topical Cream, 5% |
| ELIDEL® |
(pimecrolimus) Cream, 1% for Topical Use |
| HYLATOPIC PLUS CREAM® |
100 g Tube |
| HYLATOPIC PLUS FOAM® |
100 g Canister |
| HYLATOPIC PLUS LOTION® |
14 oz Bottle |
| JUBLIA® |
(efinaconazole) Topical Solution, 10% 4 mL or 8 mL |
| LACRISERT® |
(hydroxypropyl cellulose ophthalmic insert) |
| LOCOID LIPOCREAM® |
Cream 45 g |
| LOCOID® |
(hydrocortisone butyrate) Lotion, 0.1%, for Topical Use |
| LOTEMAX® |
(loteprednol etabonate ophthalmic gel) 0.38% or 0.5% |
| LUZU® |
(luliconazole) Cream, 1% for Topical Use |
| MEPHYTON® |
(phytonadione) Vitamin K1 Tablets |
| MOVIPREP® |
(polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution) |
| NORITATE® |
(metronidazole cream) Cream, 1% for Topical Use Only |
| ONEXTON® |
(clindamycin phosphate and benzoyl peroxide) Gel, 1.2% or 3.75% for Topical Use |
| OXSORALEN-ULTRA® |
(methoxsalen capsules, USP, 10 mg) Capsules |
| PLENVU® |
(PEG 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride), Powder for oral solution |
| PROLENSA® |
(bromfenac ophthalmic solution) 0.07% |
| RELISTOR® |
(methylnaltrexone bromide) Tablets, for Oral Use, 90-count |
| RELISTOR® |
(methylnaltrexone bromide) injection, for subcutaneous use
(7 single-dose pre-filled syringes per carton) 8 mg/0.4 mL or 12 mg/0.6 mL |
| RENOVA® |
(tretinoin cream) 0.02% for Topical Use, Pump |
| RETIN-A CREAM® |
45 gm 0.025% or 0.05% or 0.1% |
| RETIN-A GEL® |
45 gm 0.01% or 0.025% |
| RETIN-A MICRO® |
(tretinoin) Gel Microsphere for Topical Use 0.06% or 0.08% |
| RETISERT® |
(fluocinolone acetonide intravitreal implant) 0.59 mg for Intravitreal Use |
| SILIQ® |
(brodalumab) injection, for subcutaneous use, 210 mg/1.5 mL solution |
| SOLODYN® |
(minocycline HCI) Extended Release Tablets for Oral Use 55 mg or 80 mg or 105 mg |
| SYPRINE® |
(trientine hydrochloride) Capsules |
| TARGRETIN® |
(bexarotene) Capsules, for Oral Use |
| TARGRETIN® |
(bexarotene) Gel 1% |
| TASMAR® |
(tolcapone) Tablets |
| TETRIX CREAM® |
90 g Tube |
| TIMOPTIC® |
in OCUDOSE® (timolol maleate ophthalmic solution) 0.25% or 0.5% |
| TRULANCE® |
(plecanatide) 3 mg Tablets |
| UCERIS® |
(budesonide) Rectal Foam |
| VISUDYNE® |
(verteporfin for injection), for Intravenous Use |
| VYZULTA™ |
(latanoprostene bunod ophthalmic solution) 0.024% |
| XIFAXAN® |
(rifaximin) Tablets, for Oral Use, 550 mg |
| ZELAPAR® |
(selegiline hydrochloride) Orally Disintegrating Tablets |
| ZIRGAN® |
(ganiciclovir ophthalmic gel) 0.15% |
| ZIANA® |
(clindamycin phosphate 1.2% and tretinoin 0.025%) Gel 60 g tube |
| ZYCLARA® |
(imiquimod) cream 3.75%, for Topical Use 7.5 g Pump Box of 28 Packets |
| ZYLET® |
(loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) |